This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. AN15368 (Anacor Pharmaceuticals) is an oral Cleavage And Polyadenylation Specificity Factor (CPSF3) inhibitor being developed for Chagas disease, also…
molecule
4 months ago ●
5 mins read
We did a comprehensive review of industry news in 2022Q1 (there was.. a lot of stuff to cover). In this…
Article
11 months ago ●
10 mins read
Context. UCB7362(UCB Biopharma) is an oral plasmepsin X (PMX) inhibitor being developed as an antimalarial agent. Malaria is a protozoan…
molecule
4 months ago ●
5 mins read
The gem-dimethylcyclopropyl group is a key element in drugs, candidates, and agrochemicals, with a recent example being nirmatrelvir, the active…
Article
11 months ago ●
5 mins read
Context. BAY-069 (Bayer) is a branched-chain amino acid transaminase (BCAT) 1/2 inhibitor. Involved in the synthesis and breakdown of branched-chain…
molecule
4 months ago ●
4 mins read
We did a comprehensive review of industry news in 2022Q1 (there was.. a lot of stuff to cover). This article…
Article
11 months ago ●
4 mins read
Load More
